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Introduction
Seasonal allergic rhinitis (SAR), commonly known as hayfever, is a common and growing challenge in Primary Care. Increasing numbers of patients present with symptoms [1] and suboptimal use of medication is widespread [2] . The reported incidence of SAR is between 2-15%, depending on the diagnostic criteria and population [3] . The prevalence of SAR in UK school children has increased since the 1960s [1, 4, 5] and the lifetime prevalence of SAR also continues to increase in adults [6] . This rising prevalence has been reflected in increased use of health services. Consultations with general practitioners (GPs) have increased [1] : the number of patients of all ages consulting GPs for SAR in England and Wales (ICD9-477) doubled between 1971-1991 [6] . Between 1991 and 2004, Primary Care prescriptions for nasal allergy increased by over 60% (from 2.7 to 4.5 million/year) and ocular antiinflammatory prescriptions increased by 50% to 1.4 million/year [6] . While increases in prevalence statistics may reflect increased patient awareness or altered diagnostic practice, the increase in prescriptions does confirm that more people are seeking treatment for SAR [7] .
Common symptoms of SAR include sneezing, runny or blocked nose and itchy eyes [2, 8] . Despite the availability of a wide range of symptom-relieving medications, SAR can significantly affect sufferers' perceived health and quality of life [9] [10] [11] [12] [13] [14] . Only a minority of SAR patients report good symptom control, although this statistic may be skewed because many people with SAR (44%) do not consult a clinician [15] . Suboptimal use of medication and poor symptom control may result from not taking medications as instructed [2] , which in other illnesses has been shown to be influenced by patients' beliefs [16, 17] .
Leventhal's Common Sense Model of self regulation of health and illness (SRM), provides a three-stage framework for understanding how symptom-based and psychological factors combine to form patients' own model of illness and how this influences coping strategies and outcomes [18, 19] . Firstly, the person constructs cognitive and emotional representations of the health threat. These reflect internal cues (symptoms), and/or external cues (information from friends, family and healthcare professionals). Five cognitive representations are described: identity: the signs and symptoms and the arbitrary label given to the condition; cause: the individual's perceived cause of the condition, which may differ from healthcare professionals' views; time-line: beliefs about the likely duration of the condition; consequences: beliefs about the consequences of the condition for the individual and his/her life; curability/controllability: beliefs about whether the condition can be cured or controlled, including how much the individual can control this. Alongside these cognitive representations, the SRM includes emotional representations which reflect the emotional responses to the condition.
At stage two, the individual adopts an action plan or coping procedure linked to their beliefs and emotions. Personal strategies may aim to achieve and maintain symptomatic control by seeking advice and medication (problem-focused coping) or may involve avoiding going outdoors, taking time off work, or reducing anxiety by meditating (emotion-focused coping). The third stage is coping appraisal, which involves evaluating the effectiveness of the coping strategy in dealing with the threat (in this case the symptoms of SAR). This evaluation feeds back to influence illness representations and coping strategies. The underlying aim is to restore the status quo, cognitively, physically and emotionally. If the patient is prescribed medication, their beliefs about medication will probably impact on coping mechanisms and outcomes [20] so it is useful to measure these in addition to illness beliefs [16, 21] .
The SRM has been used to study patient beliefs in many illnesses [22] [23] [24] including asthma [16, 25, 26] , leading to better understanding of how patients perceive and cope with chronic conditions and how beliefs affect health outcomes such as depression and quality of life. In patients with myocardial infarction (MI) interventions to change inappropriate cognitions regarding their illness have facilitated faster recovery rates [27] and provided patients with a greater sense of control over their illness [28] . Research on self-managed illnesses such as asthma has addressed the impact of illness and medication beliefs on adherence to medication [16, 25, 26] but these findings still await translation into effective patient interventions.
The illness representations of patients with SAR have not been studied, although one recent study looked at allergies in general [29] . The present study aimed to explore the beliefs that SAR patients hold regarding their illness and treatments, and to determine whether patients could be usefully classified according to the configuration of their illness beliefs.
Methods Design
Cross-sectional postal questionnaire survey.
Participants
Adult patients (aged 17-65 years) who had consulted with SAR at least once in the preceding two years were identified from computerised records of four General Practices in Southern England.
Procedure
Questionnaires were distributed to a 20% random sample of patients with SAR in August, at the end of the grass pollen season. Selfcompletion packs were distributed with a covering letter from the GP, and a freepost reply envelope.
Demographic and descriptive data
Age, gender, current symptoms and age of symptom onset were collected by questionnaire.
Measures
The following self-completed measures were used to elicit illness representations and medication beliefs:
Revised Illness Perception Questionnaire (IPQ-R): The revised Illness Perception Questionnaire (IPQ-R) [30] was chosen to assess patient's beliefs and understanding of their illness, as it has proven validity and reliability across a range of illness groups. It provides a quantitative measure of the nature and strength of patient cognitions and emotional representations on nine subscales.
The illness identity scale assesses the number and nature of symptoms that patients endorse as part of their condition. Participants are asked to state whether they have experienced any of 14 general symptoms (e.g. fatigue, sore eyes, headaches, sleep difficulties) since their illness began. They are then asked whether they believe the symptom to be specifically due to hayfever (yes/no) which are then summed to give the illness identity subscale score. The causal scale assesses personal perceptions of the likely cause of the illness and contains a core set of 18 belief items (e.g. pollution, diet, overwork). For this study 'pollen' was added as an additional causal item.
Illness cognitions are assessed through five subscales: perceived consequences of the illness (6 items, score 6-30) concerned with the expected effects and outcomes of the illness e.g. 'my hayfever causes difficulties for those that are close to me'; how much personal control the patient feels they have over their illness (6 items, score 6-30) e.g. 'what I do can determine whether my hayfever gets better or worse'; timeline-chronic assesses how long the patient thinks their illness will last (6 items, score 6-30) e.g. 'I expect to have hayfever for the rest of my life'; timeline -cyclical assesses perceptions about the pattern of their symptoms (4 items, score 4-20) e.g. 'my symptoms come and go in cycles'; and treatment control assesses the impact of treatment on control of the condition (5 items, score 5-25) e.g. 'my treatment can control my hayfever' . The emotional representation the patient holds towards their illness (6 items, score 6-30) e.g. 'I get depressed when I think about my hayfever' and illness coherence/understanding which assesses whether patients' comprehend their illness (5 items, score 5-25) e.g. 'I have a clear picture or understanding of my hayfever' are also assessed. These seven subscales are computed from responses to a series of statements to which the respondent indicates their agreement on a 5-point Likert scale, ranging from 1=strongly disagree to 5=strongly agree. Higher scores indicate stronger beliefs.
Beliefs about Medicines Questionnaire-Specific (BMQ-specific):
Patients' views about the medication prescribed for their hayfever were assessed using the Specific version of the Beliefs about Medicines Questionnaire (BMQ), which has been validated for use in a range of clinical conditions and has been shown to have good internal consistency and test-retest reliability [31] . The BMQ-specific measure comprises two 5-item scales assessing personal beliefs about the necessity of the specifically prescribed medication for controlling their illness and concerns about the potential adverse consequences of taking it. In the BMQ-HF devised for this study, the word 'medicines' was replaced with 'antihistamine tablets' , 'nasal spray' and 'eye drops' , to create three versions of the specific measure. Respondents indicate their degree of agreement with each of the 10 items on a 5-point Likert scale, (1=strongly disagree; 5=strongly agree). Items are summed to give a necessity and concerns 
Statistical analysis
Statistical analysis was conducted using SPSS v14 for Windows. Missing items from IPQ-R scales were addressed by mean imputation as advised by the scale developer: if more than half of the subscale items were completed, the missing items were assigned values equal to the average of the completed items.
Results

Participants
Of the 586 questionnaires sent, 316 were returned (54% response rate). 61% of respondents were female (61%); mean age 40 years (SD 12.47). 81% reported moderate or severe symptoms and 76% reported symptoms ≥ 4 days/week for more than 4 weeks in the preceding hayfever season. 63% reported using oral antihistamines regularly, 37% used nasal sprays regularly and 22% used eye drops regularly (Table 1) .
Patient beliefs
All illness and treatment belief subscales demonstrated acceptable internal consistency with Cronbach's Alpha ranging from 0.70-0.91 ( Table 2 ).
The most common symptoms attributed to SAR were sore eyes (91%), sore throat (66%), wheeziness (63%), fatigue (55%), breathlessness (55%), sleep difficulties (53%) and headaches (49%). Some participants blamed hay fever for symptoms not commonly associated with SAR, e.g. upset stomach, loss of strength, pain, and nausea.
As causes of SAR, patients mainly endorsed immune and risk factors beyond their control, such as pollen (93%), pollution (73%), inherited condition (43%), altered immunity (32%). Fewer respondents selected psychological attributions such as stress/worry (16%), or emotional state (9%) ( Table 3 ) [30] .
Relationships between patient beliefs and demographic factors
Females were more likely than males to believe that their hayfever was permanent or would last a long time (p=0.025). With increasing age, perceptions of personal controllability of their illness increased (r=0.13; p=0.025) as did beliefs about needing to take antihistamines (r=0.15; p=0.015) and concerns about nasal sprays (r=0.19; p=0.009).
Later onset of SAR correlated positively with stronger perceptions of controllability of illness by treatment (r=0.14; n=297; p=0.019), more concerns about antihistamines (r=0.17; p=0.01) and nasal sprays (r=0.15; p=0.047), and weaker beliefs that hayfever would last a long time or be permanent (r=-0.15; p=0.008).
People with earlier age of onset were more likely to report better understanding of their hayfever (illness coherence) than those whose symptoms started later (r=-0.28; n=297; p ≤ 0.001). Longer illness duration was associated with stronger beliefs in personal control (r=0.25; p ≤ 0.001), weaker beliefs in treatment control (r=-0.12; p=0.03), perceptions that the illness would continue (r=0.15; p=0.008) and a better understanding of the illness (illness coherence) (r=0.30; p ≤ 0.001). Although statistically significant, these relationships were all relatively modest.
Relationships between illness and medication beliefs (Table  4) Moderate associations (r ≥ 0.4) were found between beliefs that SAR has more severe consequences for the individual and concerns about medication. Stronger beliefs in the necessity for antihistamines were related to stronger illness identity and to more negative perceptions of the consequences of SAR. Participants reporting a better understanding of their illness (high illness coherence scores) tended to have fewer concerns about medication (nasal spray, antihistamine tablets and eye drops) than those reporting poor understanding of their SAR ( Relationships between illness and medication belief subscales and demographic factors were explored using Spearman's rank correlation coefficients (Mann-Whitney U test for gender). Patient subgroups were identified by hierarchical agglomerative cluster analysis of IPQ-R subscale scores, using Ward's method [32] , taking as the resemblance coefficient, the squared Euclidean distance between illness beliefs as measured by the seven cognitive and emotional subscales of the IPQ-R [33] . As IPQ-R subscales contain differing numbers of items, values were standardised by transformation into Z scores. The agglomeration schedule was examined to determine the most appropriate number of clusters in the data. Independent sample t-tests (95% confidence intervals and equal variance assumed), were conducted to determine whether there were any significant differences between clusters in medication beliefs, age, duration of illness and age of SAR onset. Cluster differences in gender and experience of symptoms was investigated using Chi 2 tests.
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Emotional representations were positively associated with all medication beliefs, indicating that those with stronger medication concerns and beliefs in the need for medication were more likely to report being upset or depressed by SAR.
Identification of two sub-groups of hayfever patients
Cluster analysis of illness representations identified two subgroups of patients (Figure 1 ). Broadly speaking, 58% had 'positive' beliefs and 42% had 'negative' beliefs. These two groups were similar in terms of age (t=-0.61; df=311; p>0.05), age of onset (t=-0.03; df=295; p>0.05), gender (χ2=0.49; p>0.05) and duration of illness (t=-0.72; df=295; p>0.05). However, those with negative beliefs were more likely to experience hayfever symptoms ≥ 4 days/week during the season (χ 2 =20.93; p<0.001) and to perceive their symptoms as more severe (χ 2 =41.70; p<0.001).
Those with negative beliefs were more likely to perceive their illness as having greater emotional impact, greater consequences for their lives and as lasting longer. This group also reported a poorer understanding of their illness than those holding positive beliefs (Table 5) . Consistently, those holding more negative beliefs attributed more symptoms to their hayfever, perceived they had less personal control over their
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Illness identity (n=237) 6.73 (3.37) illness and were less likely to believe that treatment could control their hayfever (Table 5) .
Patients with more negative beliefs about their SAR had stronger belief in the necessity of taking antihistamine tablets to improve their health, but there was no difference for nasal sprays or eye drops (Table  5) . However, patients with more negative beliefs reported greater concerns about all three types of medication (Table 5) .
Discussion
This is the first study to use the SRM framework to explore the beliefs of patients with hayfever about their illness and its treatment [18, 19] . The analysis revealed clear patterns of beliefs, linked to symptom reporting and have implications for patient care.
The strongest correlations were found between illness cognitions and medication beliefs. Patients reporting good understanding of their illness were less likely to have concerns regarding medication. Those who reported strong concerns about their medication and also held strong beliefs that medication was necessary for their health were more likely to experience emotional consequences, such as being upset or depressed because of SAR.
These findings have important implications for patient management. As most SAR is managed in the community, appropriate selfmanagement is vital to optimising symptom control, and reducing disease impact. Patients' understanding of their SAR could be improved by educational strategies, including wider use by community physicians and pharmacists of existing leaflets informing patients about the causes, symptoms and likely impact of SAR and the range of available medications. Those who had experienced SAR for longer reported stronger personal control beliefs and better understanding of SAR. This may reflect an adaptive approach to self-management as patients get used to having SAR. If during the consultation, the clinician identifies someone with negative beliefs they should encourage the patient to consider alternative perspectives that may encourage adaptive problem focused coping strategies. Even those with more positive illness cognitions did not strongly believe that their treatment would be effective. There are several possible explanations beyond the simple conclusion that treatment is not very effective. Incomplete medication adherence could lead to poor symptom control, if patients believe that medication will not help their particular symptoms. Strong personal control beliefs associated with low beliefs in the necessity of medicines and high medication concerns may mean that patients use behavioural management options rather than drug therapy. These beliefs could be explored by the clinician and alternative pharmaceutical options discussed.
In general, patients did not strongly believe that their medication was necessary to their health. Patients' beliefs about medication are not necessarily rational from a medical perspective [20] , and they may be reluctant to disclose these beliefs to health professionals. Discussion of information provided in leaflets could help elicit the patient's own beliefs, concerns and expectations [34] . Having explored these and having considered them in relation to treatment alternatives, the practitioner and patient could agree an appropriate treatment plan. Through shared ownership of the decision the patient is more likely to take the medication as recommended.
For example White et al. found that 64% of hayfever patients who were prescribed regular nasal steroids and antihistamines, did not take their medication as recommended [2] . The SRM asserts that beliefs affect the coping strategies that people choose [18, 19] , and this has been shown to affect adherence to medication [16] . In the SRM, nonadherence results from incongruence within the person's illness model. Previous studies have demonstrated that stronger concerns about the potential adverse effects of medication [16, 25] and more negative timeline and cure/control beliefs [26] are related to reduced adherence levels in asthma. Interventions could be designed to address concerns about medications and to strengthen beliefs about personal control alongside treatment control.
Many patients considered their SAR was caused by pollen or pollution in the environment, or a hereditary condition. This is similar to causal beliefs reported by members of an allergy network [29] . However, a minority attributed their illness to psychological factors such as stress, worry, or their emotional state. Beliefs about cause also influence health behaviours such as following management advice and have been targets for intervention. Interventions aimed at changing the causal beliefs of patients (e.g. patients whose perceptions of the cause of their myocardial infarction were unrelated to epidemiological evidence) have successfully changed patient outcomes [27] . Little work has been conducted in other, less serious conditions. Examining patterns of beliefs may be better for identifying 'at risk' groups for intervention than targeting individual beliefs [33] . Cluster analyses have been applied to many patient groups, including those with chronic pain [35] and hypertension [36] . In the present study, cluster analysis revealed that people with more negative belief patterns were more likely to perceive that their SAR would be permanent, and perceived more severe consequences. This subgroup had less understanding of SAR and reported stronger emotional representations, as compared to patients with more positive beliefs. Patients with more negative beliefs about SAR were also more likely to believe in taking antihistamines. The lack of relationships between beliefs and use of nasal sprays or eye drops may reflect the smaller numbers using these, or perhaps the more targeted nature of symptom relief as compared to antihistamine tablets. Negative illness perceptions have been linked to higher levels of psychological distress and less adaptive coping strategies in allergy sufferers [29] : perhaps those reporting more negative beliefs may be at increased risk of these outcomes. Future studies could clarify how patterns of beliefs link to anxiety and depression, coping style and adherence. Interventions could focus on promoting more positive beliefs and teaching new coping strategies (pharmacotherapy and behavioural approaches).
The present study has some limitations. The cross-sectional design means we cannot determine whether medication beliefs cause beliefs about the illness or vice versa. Similarly, as SAR symptoms vary according to time of year, beliefs captured at one time point may not remain stable all year round. A repeated measures design would better capture the cyclical nature of SAR and indicate the optimum timing for intervention. The sample only included patients who have consulted a general practitioner and ignores those who only self-medicate with over the counter remedies. It remains unknown whether beliefs or symptom severity differ between these two groups.
Despite these limitations, the study findings are relevant to clinical practice. If clinicians gain a better understanding of their patients' views about their illness and treatment, this creates a firmer foundation for clinician-patient partnership [37] . Our findings demonstrate that the SRM illness perceptions approach offers a useful framework for eliciting patients' underlying cognitive models of SAR and may help facilitate discussion about self management strategies with those holding negative beliefs, with the aim of arriving at appropriate and mutually agreed treatment plans.
